Tag: Assets
At Highs Snaps, we believe powerful data is the key driver to making smarter decisions, achieving higher cost saving, and improving project timelines
Imagine monitoring a construction site or inspecting an asset without leaving the comfort of your desk? Well, imagine no more. With the power of drones, we can now collect high resolution aerial imagery and survey-grade data and turn it into a digital replica that can be completely navigated and inspected virtually. This allows interaction with Dark Land Survival Announces Its Launch, Born to Revolutionize the GameFi Industry
Singapore, Feb 23, 2022 - (ACN Newswire) - A Big Cat Studio's brainchild named "Dark Land Survival" was born to revolutionize the GameFi space with unique feature called "Smart Staking".
2021 was a booming year for NFT Game trends, seeing many success stories that have shifted blockchain games from an unproven concept to an opportunity that even traditional game publishers are seizing. With NFT, or Play-to-earn games hitting the mainstream, people are becoming more and more familiar with the idea that the GameFi ecosystems can actually provide users with real financial incentives and social values. They are also gradually starting to recognize the accumulation of digital assets as an investment with long-term benefits.
However, the rapid development of the blockchain entails numerous unresolved risks that still trigger doubt and uncertainty about the practicality of this breakthrough technology. Therefore, the growth of NFT Games is still facing tremendous obstacles, mainly stemming from a difficult-to-close mindset gap between the traditional gaming community and the P2E players. This is also greatly affected by the imbalance between the NFT Game gameplay (the "play" part) and the activities of reaping rewards by playing (the "earn" part) - a seemingly never ending issue that most NFT Games in the market have yet to settle.
Fortunately, Inspired by the global hit "Axie Infinity", Dark Land Survival, a GameFi project built by Big Cat Studio - a Singapore-based game publisher is pioneering to revolutionize the NFT industry, solving the nerve-racking mentioned issues by following 2 approaches:
An unique mechanism called "Smart Staking" that can attract a lot of traditional players.
Various never-before-seen modes for an NFT IDLE Defense game built that are powered by blockchain.
"Smart Staking" - a promising unique feature, inspired by the wildly popular "Axie Infinity"
In this "Smart Staking" mechanism, investors or players with excess resources (NFTs, tokens) can stake these assets into nft / token pools. Developers will use this pool to provide initial resources for traditional users to use to play games. All staked assets still belong to the original owners, and additionally, the number of resources benefited by the initial capital will also belong to them. Only a part of which, when reaching a certain threshold, will be paid to traditional non-crypto users who have played the game without investing tokens into the game. At this point, the traditional user will have an option to convert that small portion of the payment to Dark Land's tokens through the blockchain network and will be instructed to create a wallet and finally be able to officially own the earned assets.
The team reckons that letting conventional players notice potential financial gains first before their actual investment will encourage them to adopt the use of crypto softwares and protocols. With this mechanism, the current biggest barriers making it difficult for nft game developers such as users having to own wallets and users having to put in initial capital will be significantly resolved.
Additionally, DLS believes that smart staking and the utilization of the traditional marketing methods will surely help drive the mass adoption of blockchain technology. User acquisition through ad networks is very common with traditional game publishers, where it is completely normal to bring in several hundred thousand new users/day. However, the inherent barrier of nft games makes it difficult for the game to launch in store and also difficult for users to access. By initiating the "smart staking" feature, or in other words, allowing non-crypto players to experience the game first, and combine it with an approach of growth marketing strategies for traditional games, Dark Land Survival can release a huge demand for the game's ecosystem in particular and the blockchain ecosystem in general.
If successful, it will be a groundbreaking resolution, opening a new door of access for traditional users and paving the way for other NFT projects to thrive.
Gameplay PvP modes in a Zombie IDLE Defense game, a new approach.
The essence of most games ever developed is clearly the competition among players, and the success of them mostly lies in their gameplay. Dark Land Survival possesses a compelling game mode that is not only newcomer-friendly, but also promises very high competitiveness. In the PvP - Dungeon gameplay, players will participate in PvP events, either 1vs10 or 1vs99 to compete with each other for valuable rewards such as NFTs. For example, in "PvP Dungeon - Fight for land" mode, the player who wins the match (e.g 1vs10) will win a very valuable NFT Land with the number of resources waiting to be exploited.
Similarly, in a different mode called "Dungeon - Treasure Hunt", an event will take place in a specific Land area - owned by a player (now a landlord) - where an item box will be placed and the player will have to surpass 99 other opponents (in a battle-royale style) to win a lucrative NFT box. In addition, different Dungeon and Quest modes will also be further designed based on the location and other characteristics of the Land, which will be updated later in the project.
Private round has ended, now it's time to move forward.
Dark Land Survival recently closed its massively oversubscribed private round, which "exceeded the team's humble expectations" - said Lily Nguyen - CEO. "With enough funding, we're confident in materializing our ambitious dream of creating an actual impact, not only to the crypto realm, but also to society".
Its IDO date has yet to be finalized, but the team planned to hold a multi-launchpad IDO event for $BIG token tentatively in March.
About Dark Land Survival
Dark Land Survival is more than just a NFT IDLE Zombie Defense Game powered by blockchain technology; Built on BSC, it's a massive open world that comes with a whole new perspective. Aside from the Play to Earn mechanic with a rich story, Dark Land Survival offers a superior gaming experience with various gameplay modes and features such as campaign, dungeon, raid mode, construction mode, landlord, and more? All of which encourage players to keep playing and exploring.
Social Links
Telegram: https://t.me/DarkLandSurvival
Telegram2: https://t.me/DarkLandSurvival2
Telegram Announcement: https://t.me/DarkLandSurvivalAnnounce
Twitter: https://twitter.com/DarkLandGame
Facebook: https://www.facebook.com/Dark-Land-Survival-102228218990976
Discord: https://dsc.gg/darklandsurvival
Youtube: https://www.youtube.com/channel/UC29_ydawYyxoDw7hlMASI1g
Medium: https://medium.com/@darklandsurvival
Media Contact
Brand: Dark Land Survival
Contact: Lily Nguyen, CEO
E-mail: contact@darkland.io
Website: https://darkland.io/
SOURCE: Dark Land Survival
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.com
Q&M Dental records historic highest-ever revenue and profit after tax for year ended 31 December 2021 and declares a full year dividend yielding 7%
 |
Quarterly Financial Performance since the start of Covid-19 (From 4Q2019)
The Covid-19 pandemic had no impact on the Group's core dental and medical clinics business segment and continued its strong growth trend. On a Quarterly basis, the Group's revenue also recorded a steady increase from S$36.4 million in 4Q2019 to S$53.3 million in 4Q2021.
FY2021 Financial Performance
For the FY2021, total revenue improved by S$68.0 million or 49% from S$137.6 million to S$205.6 million. Revenue from dental and medical clinics increased by 27% to S$160.2 million. The increase was mainly due to higher revenue from existing and new dental clinics in Singapore.
Revenue from medical laboratory and dental equipment & supplies segment jumped by 304% to S$45.4 million. The increase was mainly due to revenue from the Group's Covid-19 medical laboratory business. The medical laboratory license from MOH was obtained in September 2020.
The Group's EBITDA for FY2021 correspondingly increased by 68% to S$63.3 million, from S$37.7 million in the previous period.
The Group's net profit after tax in FY2021 increased by 98% to S$39.4 million from the S$19.8 million recorded in FY2020. PATMI (Profit after tax attributable to Shareholders excluding Minorities) grew by 55% to S$30.5 million, from S$19.7 million in the previous period.
Earnings per share increased to 3.23 Singapore cents for FY2021, from 2.09 Singapore cents in the previous period.
As at 31 December 2021, the Group's financial position remains strong with net assets of S$97.8 million, as well as cash and cash equivalents of S$47.6 million. Bank borrowings and financial liabilities amounted to S$83.7 million.
Fourth interim Dividend
The Group declares a fourth interim dividend of 1.0 Singapore cent per ordinary share for 4Q2021. In the last three quarters of 2021, the Group paid 1.0 Singapore cent in 1Q2021, 1.0 Singapore cent in 2Q2021 and 1.0 Singapore cent in 3Q2021. The total dividends work out to 4.0 Singapore cents for FY2021 translating to a 7% dividend yield based on closing share price of 56.5 cents and a dividend payout ratio of 113%. The 4Q2021 dividend will be paid on 24 March 2022.
Operational Update - Growth & Expansion in medical clinics
As at 31 December 2021, the Group has 136 dental clinics as compared to 118 in 31 December 2020, an increase of 18. The Group's number of medical clinics in Singapore remained unchanged at 5. (See Table 1)
In Singapore, the Group's number of dental clinics in Singapore grew to 97 in FY2021 from 83 in FY2020. The Group opened 15 new clinics and consolidated 1 clinic in Singapore in 2021 resulting in a net increase of 14 clinics. (See Table 2)
Similarly, for overseas, the number of dental clinics has increased to 39 in FY2021, as compared to 35 previously. 38 dental clinics are in Malaysia and 1 dental clinic is in the People's Republic of
China ("PRC"). The locations of the dental clinics in Malaysia are 15 in Johor, 18 in Kuala Lumpur and 5 in Malacca. (See Table 3).
To support this growth, the Group has also increased its total number of dentists to 270 as at 31 December 2021, as compared to 250 a year ago.
Updates on subsidiary - Acumen Diagnostics Pte Ltd
The Group continues to focus on investment opportunities in sectors that are synergistic and aligned with its business strategy. Associate Company Aoxin Q&M Dental Group Limited ("Aoxin")'s recent acquisition of a 49% shareholding of Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics"), raised Q&M's effective interest in Acumen Diagnostics to 67% from 51% in October 2021. With 1 scientist, 16 medical technologists and 36 other staff, Acumen Diagnostics' technical capabilities and infrastructure in molecular diagnostics, enables it to do research and development, manufacturing, as well as clinical laboratory testing.
- Capabilities to Tackle Omicron Covid-19 Variant
For Acumen Diagnostics, the Group will continue to offer COVID-19 testing by polymerase chain reaction ("PCR") for patients that require PCR test results and for travelers as Singapore opens its borders, as well as distribute COVID-19 antigen rapid tests ("ART"). It will also launch a panel of new PCR tests for infectious diseases, sepsis and cancer.
On 11 November 2021, Acumen Diagnostics announced that it has been granted the license by Ministry of Health, Singapore to provide door-to-door COVID-19 PCR home swab services.
On 3 December 2021, Acumen Diagnostics announced that its proprietary, locally-manufactured PCR test kits Acu-Corona 2.0 and Acu-Corona Duplex are able to detect COVID-19 positive cases infected with the Omicron variant. On 16 December 2021, Acumen Diagnostics announced that it has been granted a license by Ministry of Health, Singapore to provide offsite COVID-19 PCR swab services and serology sample collection at 100 clinics.
Acumen Diagnostics will continue to roll out its testing services via the Group's network of clinics, and also at its headquarters located at The Gemini, 41 Science Park Road, Singapore. Currently, the Company has about 61 clinics providing the testing services island-wide.
- Appoints UOB Kay Hian Private Limited as Arranger to Explore NASDAQ Listing
On 17 January 2022, Q&M announced that Acumen Diagnostics is exploring a proposed listing of its securities on the NASDAQ stock exchange in New York, USA. Acumen Diagnostics has appointed UOB Kay Hian Private Limited to assist Acumen Diagnostics with the listing evaluation and all relevant preparatory work including the selection of professional advisers and underwriting banks in relation to the proposed NASDAQ listing and fundraising exercise.
Looking Forward - Expansion Plans
Dr Ng Chin Siau, said "Q&M will embark on 4 pillars of growth. Firstly, expansion of our core dental business in Singapore, Malaysia as well as South East Asia and China for sustainable growth. "Our Group intends to open at least 30 dental clinics a year from 2021 onwards in Singapore and Malaysia for the next 10 years."
Secondly, the use of medical technology such as our proprietary Artificial Intelligence Guided Clinical Decision Support System to provide the most effective and suitable treatment plans for patients This will enable us to scale up consistency and quality throughout our network clinics.
Thirdly, expand our clinical testing laboratory business to test Covid-19 and other diseases such as dengue sepsis and other bacterial pathogens.
Fourth ly, invest in medical and healthcare business that will enhance our shareholder's value such as Acumen Diagnostic."
Q&M Group will continue to execute our business plans outlined below:
1. Expansion of network of dental clinics in Singapore, Malaysia and Southeast Asia
Q&M will focus on its operations in Singapore and has initiated a strategy of intensive organic growth for its dental clinics in Singapore. It will expand its team of dentists to support the future growth of its operations in Singapore.
The Group intends to open at least 30 dental clinics a year for the next 10 years from 2021 onwards in Singapore and Malaysia and continue to look for opportunities to expand its business through the opening of new dental clinics in Southeast Asia.
The eventual number of dental outlets will depend on available opportunities, pertinent market conditions and the evolving Covid-19 situation.
2. Expansion into private dental healthcare market in China
Q&M's main thrust of expansion in China is through organic growth to develop a new and sustainable growth pillar that can yield long term value for the Group.
3. Artificial Intelligence Guided Clinical Decision Support System (AI-GCDSS)
Q&M will continue to develop, invest, and optimise its proprietary digital Artificial Intelligence (AI) Guided Clinical Decision Support System to provide the most effective and suitable treatment plans for patients. The Group believes it is well-positioned to cater to patients' rising demand for primary and higher value specialist dental healthcare services.
4. Medical Laboratory
Q&M will focus on rolling out its clinical testing laboratory's pipeline of new tests including PCR assays for dengue sepsis and the identification of bacterial pathogens and their associated antibiotics resistance in pneumonia and bloodstream infections.
Looking Forward
Barring any unforeseen circumstances, such as a rapid worsening of the Covid-19 situation in Singapore and Malaysia, there are no known significant changes in the trends and competitive conditions of the industry in which the Group operates and no other major known factors or events that may adversely affect the Group in the next reporting period and the next 12 months.
[1] Based on closing share price of 56.5 cents as at 17 February 2022
Please see links for PDF documents from SGXNET.
https://links.sgx.com/FileOpen/QnM_FY%202021_PRESS_RELEASE.ashx?App=Announcement&FileID=703150
https://links.sgx.com/FileOpen/QnM_4Q2021_Result_Announcement.ashx?App=Announcement&FileID=703149
About Q&M Dental Group (Singapore) Limited (QC7.SI) www.QandMDental.com.sg
Q&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group") is a leading private dental healthcare group in Asia. The Group owns the largest network of private dental outlets in Singapore, operating 98 dental outlets across the country. Underpinned by about 270 experienced dentists, 7 doctors and over 350 supporting staff, the Group sees an average of 40,000 patient visits a month in Singapore. The Group also operates 5 medical clinics and a dental supplies and equipment distribution company.
Outside of Singapore, the Group has 38 dental clinics and a dental supplies and equipment distribution company in Malaysia, as well as a dental clinic in the People's Republic of China ("PRC"). Q&M is also the substantial shareholder of Aoxin Q&M Dental Group Limited, a dental Group listed on the Catalist board of the Singapore Exchange, which operates dental clinics and hospitals primarily in the North- eastern region of the PRC. The Group aims to expand its operations geographically and vertically through the value chain in Malaysia, the PRC and within ASEAN.
In 2018, the Group made inroads into the development of advanced technology in healthcare with the establishment of EM2AI Pte. Ltd. ("EM2AI", formerly known as Q&M Dental AI Pte. Ltd.). EM2AI focuses on developing an Artificial Intelligence (AI) ethical enhanced guided treatment plan.
In 2019, the Group expanded into dental postgraduate education with the establishment of the Q&M College of Dentistry. It offers Singapore's first private postgraduate diploma programme in clinical dentistry.
In 2020, the Group also expanded into the medical laboratories and research industry with the incorporation of Acumen Diagnostics Pte. Ltd. ("Acumen Diagnostics"). Acumen Diagnostics currently focuses on the manufacture, sale and distribution of COVID-19 diagnostic test kits, as well as COVID-19 testing.
The Group was listed on the Mainboard of the Singapore Exchange Securities Trading Limited ("SGX- ST") on 26 November 2009.
For more information, please contact:
Waterbrooks Consultants Pte Ltd
Tel: +65 6958 8008 (M) +65 9690-4959 email: query@waterbrooks.com.sg
Wayne Koo - wayne.koo@waterbrooks.com.sg (M) +65 933 88166
Derek Yeo - derek@waterbrooks.com.sg
Copyright 2022 ACN Newswire. All rights reserved. www.acnnewswire.comQ&M Dental Group (Singapore) Limited ("Q&M" or together with its subsidiaries, the "Group"), a leading private dental healthcare group in Asia, today reported the highest-ever revenue and profit after tax of S$205.6 million and S$39.4 million respectively for the financial year ended 31 December 2021 ("FY2021").
Latest Intelligence
